Drug
HS-20094 Injection
HS-20094 Injection is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_3
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 33 (100.0%)
Trials by Status
recruiting133%
not_yet_recruiting267%
Recent Activity
1 active trials
Showing 3 of 3
not_yet_recruitingphase_3
A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone
NCT07156500
not_yet_recruitingphase_3
A Phase 3 Study of HS-20094 in Patients With T2DM
NCT07156539
recruitingphase_3
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
NCT06839664
Clinical Trials (3)
Showing 3 of 3 trials
NCT07156500Phase 3
A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone
NCT07156539Phase 3
A Phase 3 Study of HS-20094 in Patients With T2DM
NCT06839664Phase 3
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3